Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaxolol for acute phase management of mild to moderate traumatic brain injury
IRCT20240415061488N1Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of betaxolol in traumatic brain injury (TBI), sponsored by Baqiyatallah University of Medical Sciences. Started May 2024; status: completed.
02
Drugs
betaxolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20240415061488N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240415061488N1.